Us Physicalrapy Stock Performance

USPH Stock  USD 85.58  1.51  1.80%   
On a scale of 0 to 100, US Physicalrapy holds a performance score of 10. The entity owns a Beta (Systematic Risk) of 1.39, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, US Physicalrapy will likely underperform. Please check US Physicalrapy's coefficient of variation, semi variance, price action indicator, as well as the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether US Physicalrapy's current price history will revert.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in US Physicalrapy are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite fairly fragile basic indicators, US Physicalrapy demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
1.8
Five Day Return
4.3
Year To Date Return
8.49
Ten Year Return
76.89
All Time Return
4.4 K
Forward Dividend Yield
0.021
Payout Ratio
0.9231
Last Split Factor
3:2
Forward Dividend Rate
1.8
Dividend Date
2025-12-12
1
U.S. Physical Therapy Exploring Valuation After Recent Share Price Decline
11/12/2025
2
Share Buyback and Insider Activity Could Be a Game Changer for U.S. Physical Therapy
12/01/2025
3
4D Advisors Initiated a Big Position in USPH Worth Over 9 Million. Is the Stock a Buy
12/09/2025
4
ADUS or USPH Which Is the Better Value Stock Right Now
12/11/2025
 
US Physicalrapy dividend paid on 12th of December 2025
12/12/2025
5
U.S. Physical Therapy Stock Trades Up, Here Is Why
12/22/2025
6
Why Are U.S. Physical Therapy Shares Soaring Today
01/05/2026
7
U.S. Physical Therapy Is Up 8.1 percent After 17.3 percent Revenue Gain And Upbeat Analyst Sentiment
01/15/2026
8
U.S. Physical Therapys Operating Model Gains Fresh Market Interest
01/30/2026
9
Acquisition by Swanson Regg E. of 1882 shares of US Physicalrapy subject to Rule 16b-3
02/04/2026
Begin Period Cash Flow152.8 M
Total Cashflows From Investing Activities-149.4 M

US Physicalrapy Relative Risk vs. Return Landscape

If you would invest  7,392  in US Physicalrapy on November 11, 2025 and sell it today you would earn a total of  1,166  from holding US Physicalrapy or generate 15.77% return on investment over 90 days. US Physicalrapy is currently generating 0.2603% in daily expected returns and assumes 2.0228% risk (volatility on return distribution) over the 90 days horizon. In different words, 18% of stocks are less volatile than USPH, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days US Physicalrapy is expected to generate 2.51 times more return on investment than the market. However, the company is 2.51 times more volatile than its market benchmark. It trades about 0.13 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.09 per unit of risk.

US Physicalrapy Target Price Odds to finish over Current Price

The tendency of USPH Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 85.58 90 days 85.58 
about 12.5
Based on a normal probability distribution, the odds of US Physicalrapy to move above the current price in 90 days from now is about 12.5 (This US Physicalrapy probability density function shows the probability of USPH Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.39 . This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, US Physicalrapy will likely underperform. Additionally US Physicalrapy has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   US Physicalrapy Price Density   
       Price  

Predictive Modules for US Physicalrapy

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as US Physicalrapy. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
83.5785.5987.61
Details
Intrinsic
Valuation
LowRealHigh
77.0293.5295.54
Details
7 Analysts
Consensus
LowTargetHigh
95.85105.33116.92
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.640.660.67
Details

US Physicalrapy Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. US Physicalrapy is not an exception. The market had few large corrections towards the US Physicalrapy's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold US Physicalrapy, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of US Physicalrapy within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.1
β
Beta against Dow Jones1.39
σ
Overall volatility
5.46
Ir
Information ratio -0.03

US Physicalrapy Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of US Physicalrapy for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for US Physicalrapy can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Over 98.0% of the company outstanding shares are owned by institutional investors
Latest headline from finance.yahoo.com: AdaptHealth Corp. Delivered A Weaker ROE Than Its Industry

US Physicalrapy Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of USPH Stock often depends not only on the future outlook of the current and potential US Physicalrapy's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. US Physicalrapy's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding15.1 M
Cash And Short Term Investments41.4 M

US Physicalrapy Fundamentals Growth

USPH Stock prices reflect investors' perceptions of the future prospects and financial health of US Physicalrapy, and US Physicalrapy fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on USPH Stock performance.

About US Physicalrapy Performance

By evaluating US Physicalrapy's fundamental ratios, stakeholders can gain valuable insights into US Physicalrapy's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if US Physicalrapy has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if US Physicalrapy has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.07  0.10 
Return On Capital Employed 0.05  0.05 
Return On Assets 0.02  0.02 
Return On Equity 0.05  0.08 

Things to note about US Physicalrapy performance evaluation

Checking the ongoing alerts about US Physicalrapy for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for US Physicalrapy help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Over 98.0% of the company outstanding shares are owned by institutional investors
Latest headline from finance.yahoo.com: AdaptHealth Corp. Delivered A Weaker ROE Than Its Industry
Evaluating US Physicalrapy's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate US Physicalrapy's stock performance include:
  • Analyzing US Physicalrapy's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether US Physicalrapy's stock is overvalued or undervalued compared to its peers.
  • Examining US Physicalrapy's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating US Physicalrapy's management team can have a significant impact on its success or failure. Reviewing the track record and experience of US Physicalrapy's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of US Physicalrapy's stock. These opinions can provide insight into US Physicalrapy's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating US Physicalrapy's stock performance is not an exact science, and many factors can impact US Physicalrapy's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for USPH Stock analysis

When running US Physicalrapy's price analysis, check to measure US Physicalrapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy US Physicalrapy is operating at the current time. Most of US Physicalrapy's value examination focuses on studying past and present price action to predict the probability of US Physicalrapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move US Physicalrapy's price. Additionally, you may evaluate how the addition of US Physicalrapy to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance